株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

バイオテクノロジー試薬の世界市場の予測

Global Biotechnology Reagents Market Forecast 2020-2028

発行 Inkwood Research 商品コード 557737
出版日 ページ情報 英文 174 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.11円で換算しております。
バイオテクノロジー試薬の世界市場の予測 Global Biotechnology Reagents Market Forecast 2020-2028
出版日: 2019年09月12日 ページ情報: 英文 174 Pages
概要

当レポートでは、バイオテクノロジー試薬の世界市場について調査し、技術・用途・地域別の市場動向および市場規模の予測、市場促進・阻害要因ならびに市場機会・課題の分析、市場の将来展望、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

  • 市場概要
  • 主な調査結果

第4章 市場力学

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第5章 市場区分

  • 技術別
    • ライフサイエンス用試薬
      • ポリメラーゼ連鎖反応(PCR)
      • 細胞培養
      • インビトロ診断
      • 遺伝子発現・トランスフェクション
    • 分析用試薬
      • クロマトグラフィー
      • 質量分析
      • 電気泳動
      • フローサイメトリー
  • 用途別
    • タンパク質合成 & 精製
    • 遺伝子発現
    • DNA・RNA解析
    • 薬品検査

第6章 市場分析

  • ファイブフォース分析
  • パラメトリック分析
  • 主な購買基準
  • 戦略提言

第7章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 企業プロファイル

  • 競合環境
    • 市場シェア分析
    • 主な成功戦略
  • ABBOTT LABORATORIES
  • AGILENT TECHNOLOGIES INC.
  • BECKMAN COULTER INC.
  • BECTON, DICKINSON & COMPANY
  • BIOMERIEUX
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE CORPORATION
  • BIOTIME INC
  • C.B.S. SCIENTIFIC COMPANY INC
  • CYANO BIOTECH GMBH
  • GE HEALTHCARE
  • INVIVOSCRIBE TECHNOLOGIES INC
  • LONZA GROUP LTD.
  • MERIDIAN BIOSCIENCES INC.
  • PERKINELMER
  • SIGNALCHEM LIFESCIENCES CORP
  • THERMO FISHER

図表リスト

図表

LIST OF TABLES

  • TABLE 1: BIOTECHNOLOGY REAGENTS MARKET AT A GLANCE/MARKET SNAPSHOT/MARKET SUMMARY
  • TABLE 2: GLOBAL BIOTECHNOLOGY REAGENTS, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL BIOTECHNOLOGY REAGENTS, BY APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL PROTEIN SYNTHESIS & PURIFICATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL PROTEIN SYNTHESIS & PURIFICATION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL GENE EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL GENE EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL DNA & RNA ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL DNA & RNA ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL DRUG TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL DRUG TESTING MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL BIOTECHNOLOGY REAGENTS, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL BIOTECHNOLOGY REAGENTS, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL PCR MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL PCR MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL PCR MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL MASTER MIXES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL MASTER MIXES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL PCR REAGENT KITMARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL PCR REAGENT KIT MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL CELL CULTURE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL CELL CULTURE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL SERA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL SERA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL MEDIA AND REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL MEDIA AND REAGENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL INVITRO DIAGNOSTIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL INVITRO DIAGNOSTIC MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL INVITRO DIAGNOSTIC MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL INVITRO DIAGNOSTIC MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL EXPRESSION AND TRANSFECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL EXPRESSION AND TRANSFECTION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL ANALYTICAL REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL ANALYTICAL REAGENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL ANALYTICAL REAGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL ANALYTICAL REAGENTS MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL CHROMATOGRAPHY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL CHROMATOGRAPHY MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL MASS SPECTROMETRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL MASS SPECTROMETRY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL MASS SPECTROMETRY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL MASS SPECTROMETRY MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL ELECTROPHORESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL ELECTROPHORESIS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL ELECTROPHORESIS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL ELECTROPHORESIS MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL FLOW CYTOMETRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: GLOBAL FLOW CYTOMETRY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL FLOW CYTOMETRY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: GLOBAL FLOW CYTOMETRY MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL BIOTECHNOLOGY REAGENTS, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: GLOBAL BIOTECHNOLOGY REAGENTS, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 62: NORTH AMERICA BIOTECHNOLOGY REAGENTS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: NORTH AMERICA BIOTECHNOLOGY REAGENTS, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 64: EUROPE BIOTECHNOLOGY REAGENTS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 65: EUROPE BIOTECHNOLOGY REAGENTS, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 66: ASIA PACIFIC BIOTECHNOLOGY REAGENTS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 67: ASIA PACIFIC BIOTECHNOLOGY REAGENTS, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 68: REST OF WORLD BIOTECHNOLOGY REAGENTS, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 69: REST OF WORLD BIOTECHNOLOGY REAGENTS, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: KEY BUYING CRITERIA
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE OF BIOTECHNOLOGY REAGENTS MARKET
  • FIGURE 5: GLOBAL BIOTECHNOLOGY REAGENTS MARKET GROWTH POTENTIAL, BY APPLICATION, 2019
  • FIGURE 6: GLOBAL BIOTECHNOLOGY REAGENTS MARKET, BY PROTEIN SYNTHESIS & PURIFICATION, 2020-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL BIOTECHNOLOGY REAGENTS MARKET, BY GENE EXPRESSION, 2020-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL BIOTECHNOLOGY REAGENTS MARKET, BY DNA & RNA ANALYSIS, 2020-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL BIOTECHNOLOGY REAGENTS MARKET, BY DRUG TESTING, 2020-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL BIOTECHNOLOGY REAGENTS MARKET GROWTH POTENTIAL, BY TECHNOLOGY, 2019
  • FIGURE 11: GLOBAL BIOTECHNOLOGY REAGENTS MARKET, BY LIFE SCIENCE REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY PCR, 2020-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL PCR MARKET, BY MASTER MIXES, 2020-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL PCR MARKET, BY PCR REAGENT KIT, 2020-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY CELL CULTURE, 2020-2028 (IN $ MILLION)
  • FIGURE 16: USE OF ANIMAL SERUM MEDIA IN THE STUDY OF MESENCHYMAL STROMAL CELLS IN CELL CULTURE
  • FIGURE 17: GLOBAL CELL CULTURE MARKET, BY SERA, 2020-2028 (IN $ MILLION)
  • FIGURE 18: SUPPLIERS FOCUS ON DEVELOPMENT OF ADVANCED TECHNIQUE IN CELL CULTURE
  • FIGURE 19: GLOBAL CELL CULTURE MARKET, BY MEDIA AND REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY INVITRO DIAGNOSTIC, 2020-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL INVITRO DIAGNOSTIC MARKET, BY MICROBIOLOGY CULTURE, 2020-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL INVITRO DIAGNOSTIC MARKET, BY HEMATOLOGY, 2020-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL INVITRO DIAGNOSTIC MARKET, BY IMMUNOASSAY, 2020-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL INVITRO DIAGNOSTIC MARKET, BY CLINICAL CHEMISTRY, 2020-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL INVITRO DIAGNOSTIC MARKET, BY MOLECULAR DIAGNOSTIC, 2020-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL LIFE SCIENCE REAGENTS MARKET, BY EXPRESSION AND TRANSFECTION, 2020-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL BIOTECHNOLOGY REAGENTS MARKET, BY ANALYTICAL REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL ANALYTICAL REAGENTS MARKET, BY CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL CHROMATOGRAPHY MARKET, BY LIQUID CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL CHROMATOGRAPHY MARKET, BY GAS CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL CHROMATOGRAPHY MARKET, BY ION CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL CHROMATOGRAPHY MARKET, BY SUPER FLUID CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL CHROMATOGRAPHY MARKET, BY OTHER CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL ANALYTICAL REAGENTS MARKET, BY MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 35: GLOBAL MASS SPECTROMETRY MARKET, BY PROTEOMICS, 2020-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL MASS SPECTROMETRY MARKET, BY DRUG DISCOVERY, 2020-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL MASS SPECTROMETRY MARKET, BY GENOMICS, 2020-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL MASS SPECTROMETRY MARKET, BY CLINICAL TESTING, 2020-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL MASS SPECTROMETRY MARKET, BY OTHER MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 40: GLOBAL ANALYTICAL REAGENTS MARKET, BY ELECTROPHORESIS, 2020-2028 (IN $ MILLION)
  • FIGURE 41: GLOBAL ELECTROPHORESIS MARKET, BY GEL ELECTROPHORESIS, 2020-2028 (IN $ MILLION)
  • FIGURE 42: GLOBAL ELECTROPHORESIS MARKET, BY OTHER ELECTROPHORESIS, 2020-2028 (IN $ MILLION)
  • FIGURE 43: GLOBAL ANALYTICAL REAGENTS MARKET, BY FLOW CYTOMETRY, 2020-2028 (IN $ MILLION)
  • FIGURE 44: GLOBAL FLOW CYTOMETRY MARKET, BY CELL BASED, 2020-2028 (IN $ MILLION)
  • FIGURE 45: GLOBAL FLOW CYTOMETRY MARKET, BY CELL BASED, 2020-2028 (IN $ MILLION)
  • FIGURE 46: NORTH AMERICA BIOTECHNOLOGY REAGENTS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 47: THE UNITED STATES BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 48: CANADA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 49: EUROPE BIOTECHNOLOGY REAGENTS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 50: THE UNITED KINGDOM BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 51: FRANCE BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 52: GERMANY BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 53: BIOTECHNOLOGY APPLICATIONS IN GERMANY
  • FIGURE 54: ITALY BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 55: RUSSIA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 56: BELGIUM BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 57: POLAND BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 58: REST OF EUROPE BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 59: ASIA PACIFIC BIOTECHNOLOGY REAGENTS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 60: CHINA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 61: INDIA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 62: JAPAN BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 63: APPLICATION OF JAPANESE BIOTECHNOLOGY
  • FIGURE 64: SOUTH KOREA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 65: THAILAND BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 66: INDONESIA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 67: VIETNAM BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 68: AUSTRALIA & NEW ZEALAND BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 69: REST OF ASIA PACIFIC BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 70: REST OF WORLD BIOTECHNOLOGY REAGENTS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 71: LATIN AMERICA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
  • FIGURE 72: MIDDLE EAST & AFRICA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)
目次
Product Code: 8821

KEY FINDINGS

The global market for biotechnology reagents is predicted to exhibit a CAGR of 6.70% during the estimated period, 2020-2028. The increasing utilization of biotechnology reagents in varied applications, the increasing protein profiling applications, and the large-scale investments, are the factors boosting the growth of the market.

MARKET INSIGHTS

The global market for biotechnology reagents has constantly recorded stable growth in the last few years. The increasing research labs, bio-related technologies, and commercial requests are the primary factors pushing market growth. The evolving biotechnology industry is another important factor in driving market growth. The innovations in bioprocessing technologies and the rising number of pharma companies are driving the biopharmaceutical market.

However, the complexities and cost of biopharmaceutical research have increased, hindering the research and development process. It becomes costly for the companies to discharge the biotech reagents after using it in research. These factors are estimated to hinder the growth of the market.

REGIONAL INSIGHTS

As of 2019, the North American market region dominates in terms of market share. This is attributed to the developing pharmaceutical industry. Regionally, the United States dominates the market as a result of large-scale funding by government organizations. The region of Asia Pacific is set to be the fastest-growing market region for the biotechnology reagents market. This is due to the surging demands for GMO crops.

COMPETITIVE INSIGHTS

The stable growth standards and prospects of the market have resulted in the emergence of both, well-established and emerging players. Bio-Rad Laboratories Inc., Becton, Dickinson & Company (BD), Agilent Technologies Inc., Bio-Techne Corporation, Abbott Laboratories, Corning Inc., are the key players in the market.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of contents

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SUMMARY
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. MARKET DRIVERS
    • 3.2.1. LARGE INVESTMENT IN BIOTECHNOLOGY BY THE CORPORATES AND RESEARCH ORGANIZATIONS
    • 3.2.2. EVOLVING LANDSCAPE OF THE BIOTECHNOLOGY INDUSTRY
    • 3.2.3. INCREASING PROTEIN PROFILING APPLICATIONS
  • 3.3. MARKET RESTRAINTS
    • 3.3.1. HIGH COST OF BIOPHARMACEUTICAL RESEARCH AND DRUG DEVELOPMENT
    • 3.3.2. CONTAMINATION ISSUES
    • 3.3.3. REGULATORY DIFFERENCE IN VARIOUS COUNTRIES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. NEW ENTRANTS
    • 4.1.2. SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. INDUSTRY RIVALRY
  • 4.2. KEY BUYING CRITERIA
    • 4.2.1. SUSTAINABILITY
    • 4.2.2. QUALITY OF PRODUCT
    • 4.2.3. COST
    • 4.2.4. AVAILABILITY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY APPLICATION

  • 5.1. PROTEIN SYNTHESIS & PURIFICATION
  • 5.2. GENE EXPRESSION
  • 5.3. DNA & RNA ANALYSIS
  • 5.4. DRUG TESTING

6. MARKET BY TECHNOLOGY

  • 6.1. LIFE SCIENCE REAGENTS
    • 6.1.1. PCR
      • 6.1.1.1. MASTER MIXES
      • 6.1.1.2. PCR REAGENT KIT
    • 6.1.2. CELL CULTURE
      • 6.1.2.1. SERA
      • 6.1.2.2. MEDIA AND REAGENTS
    • 6.1.3. INVITRO DIAGNOSTIC
      • 6.1.3.1. MICROBIOLOGY CULTURE
      • 6.1.3.2. HEMATOLOGY
      • 6.1.3.3. IMMUNOASSAY
      • 6.1.3.4. CLINICAL CHEMISTRY
      • 6.1.3.5. MOLECULAR DIAGNOSTIC
    • 6.1.4. EXPRESSION AND TRANSFECTION
  • 6.2. ANALYTICAL REAGENTS
    • 6.2.1. CHROMATOGRAPHY
      • 6.2.1.1. LIQUID CHROMATOGRAPHY
      • 6.2.1.2. GAS CHROMATOGRAPHY
      • 6.2.1.3. ION CHROMATOGRAPHY
      • 6.2.1.4. SUPER FLUID CHROMATOGRAPHY
      • 6.2.1.5. OTHER CHROMATOGRAPHY
    • 6.2.2. MASS SPECTROMETRY
      • 6.2.2.1. PROTEOMICS
      • 6.2.2.2. DRUG DISCOVERY
      • 6.2.2.3. GENOMICS
      • 6.2.2.4. CLINICAL TESTING
      • 6.2.2.5. OTHER MASS SPECTROMETRY
    • 6.2.3. ELECTROPHORESIS
      • 6.2.3.1. GEL ELECTROPHORESIS
      • 6.2.3.2. OTHER ELECTROPHORESIS
    • 6.2.4. FLOW CYTOMETRY
      • 6.2.4.1. BEAD BASED
      • 6.2.4.2. CELL BASED

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. ITALY
    • 7.2.5. RUSSIA
    • 7.2.6. BELGIUM
    • 7.2.7. POLAND
    • 7.2.8. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. INDIA
    • 7.3.3. JAPAN
    • 7.3.4. SOUTH KOREA
    • 7.3.5. THAILAND
    • 7.3.6. INDONESIA
    • 7.3.7. VIETNAM
    • 7.3.8. AUSTRALIA & NEW ZEALAND
    • 7.3.9. REST OF ASIA PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. AGILENT TECHNOLOGIES INC.
  • 8.3. BECTON, DICKINSON & COMPANY (BD)
  • 8.4. BIO-RAD LABORATORIES INC.
  • 8.5. BIO-TECHNE CORPORATION
  • 8.6. CORNING INC.
  • 8.7. GE HEALTHCARE
  • 8.8. INVIVOSCRIBE TECHNOLOGIES INC
  • 8.9. LONZA GROUP LTD.
  • 8.10. MERCK KGAA
  • 8.11. MERIDIAN BIOSCIENCE INC
  • 8.12. PERKINELMER
  • 8.13. PROMOCELL GMBH
  • 8.14. SIGNALCHEM LIFESCIENCES CORPORATION
  • 8.15. VWR CORPORATION (PART OF AVANTOR)